IMPASS Trademark

Trademark Overview

On Monday, December 12, 2022, a trademark application was filed for IMPASS with the United States Patent and Trademark Office. The USPTO has given the IMPASS trademark a serial number of 97714252. The federal status of this trademark filing is REGISTERED as of Tuesday, April 2, 2024. This trademark is owned by Fluidx Medical Technology, Inc.. The IMPASS trademark is filed in the Medical Instrument Products category with the following description:

Embolic devices for creating vessel occlusion
impass

General Information

Serial Number97714252
Word MarkIMPASS
Filing DateMonday, December 12, 2022
Status700 - REGISTERED
Status DateTuesday, April 2, 2024
Registration Number7348734
Registration DateTuesday, April 2, 2024
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 24, 2023

Trademark Statements

Goods and ServicesEmbolic devices for creating vessel occlusion

Classification Information

International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateMonday, January 9, 2023
Primary Code010
First Use Anywhere DateTuesday, January 10, 2023
First Use In Commerce DateThursday, November 16, 2023

Trademark Owner History

Party NameFluidx Medical Technology, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressSalt Lake City, UT 84115
Party NameFluidx Medical Technology, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSalt Lake City, UT 84115
Party NameFluidx Medical Technology, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSalt Lake City, UT 84115

Trademark Events

Event DateEvent Description
Tuesday, April 2, 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, April 2, 2024REGISTERED-PRINCIPAL REGISTER
Thursday, February 29, 2024NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Wednesday, February 28, 2024ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Wednesday, February 28, 2024ASSIGNED TO EXAMINER
Sunday, February 4, 2024STATEMENT OF USE PROCESSING COMPLETE
Monday, January 15, 2024USE AMENDMENT FILED
Sunday, February 4, 2024CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, January 15, 2024TEAS STATEMENT OF USE RECEIVED
Tuesday, January 9, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, January 5, 2024SOU EXTENSION 1 GRANTED
Friday, January 5, 2024SOU EXTENSION 1 FILED
Friday, January 5, 2024SOU TEAS EXTENSION RECEIVED
Tuesday, December 19, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, October 24, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 24, 2023PUBLISHED FOR OPPOSITION
Wednesday, October 4, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, September 15, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, September 15, 2023EXAMINER'S AMENDMENT ENTERED
Friday, September 15, 2023NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Friday, September 15, 2023EXAMINERS AMENDMENT E-MAILED
Friday, September 15, 2023EXAMINERS AMENDMENT -WRITTEN
Friday, September 15, 2023ASSIGNED TO EXAMINER
Monday, January 9, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, December 15, 2022NEW APPLICATION ENTERED

Related Keywords

impass occlusion vessel creating devices embolic